MedPath

Software-guided Cognitive Stimulation to Prevents Delirium

Not Applicable
Completed
Conditions
Delirium in Old Age
Interventions
Other: Prevention software
Other: Placebo
Registration Number
NCT03573843
Lead Sponsor
University of Chile
Brief Summary

This study is a pilot randomized controlled trial, comparing a group of older patients with standardized non-pharmacological delirium prevention plus a basic tablet versus a group with standardized non-pharmacological delirium prevention plus a tablet with a software of cognitive stimulation (PREVEDEL).

Software:It is a local development, including a interprofessional team of delirium healthcare experts, older patients and a team og engineers. The software was developed during the first year of this project and was inscribed for author rights.

Inclusion criteria: Older patients \> 65 y.o. Admitted to medicine room or intermediate care unit \> 48 hrs, and informed consent to participate.

Exclusion Criteria:Delirium positive, neuroleptic use, dementia, and non-spanish speakers.

The study was approved by ethical committee of Hospital Clinico University of Chile Standardized Non-pharmacological intervention: Health workers were previously educated in delirium, and environmental issues were implemented. This intervention coverage in nine different domains: orientation, early mobilization, environmental noise and light, sensorial deficit, sleep, hydratation, drug reduction, and family participation.

Intervention: All patients will have a tablet with or without the software PREVEDEL between 09:00-19:00 hrs.

Measures: delirium will be monitoring with CAM (Confusion Assessment Method) twice a day for 5 days.

Primary outcome: Delirium rate between both groups Secondary outcomes:Long of stay, severity od delirium, time of use of electronic device, and Barthel to discharge.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Older patients > 65 y.o. Admitted to medicine room or intermediate care unit > 48 hrs, and informed consent to participate.

Exclusion Criteria

Delirium positive, neuroleptic use, dementia, and non-spanish speakers.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalPrevention softwarePatients who meet the inclusion / exclusion criteria will be randomly assigned to the experimental group:They will continue to receive standard prevention measures: Detection of delirium, education of health care team and the patient's family, sleep hygiene plan, early mobilization, resolve sensory impairments, and delivery of information of temporal-spatial reorientation in continuously, plus the use of software installed on a mobile device designed to support the prevention of delirium (Prevention software).
ControlPlaceboPatients who meet the inclusion / exclusion criteria will be randomly assigned to the Control group: They will continue to receive the standard prevention measures: delirium detection, treatment health team education and the patient's family, sleep hygiene plan, early mobilization , resolve sensorial deterioration, and delivery of information of temporal-spatial reorientation in a continuous manner, plus the use of a mobile device without installed delirium prevention software (placebo).
Primary Outcome Measures
NameTimeMethod
Difference in delirium incidence between both groups5 days

Delirium will be assessed with CAM (the confusion assessment method) twice a day.

Secondary Outcome Measures
NameTimeMethod
Severity of delirium5 days

Delirium will be evaluated with CAM-S (the confusion assessment method Severity) whenever appropriate.

Functionality at discharge.5 days

Functionality at discharge will be assessed with Barthel Index test at discharge.

Time of use of electronic device5 days

The usage time on the mobile device (with internal device registration) will be recorded.

Length of stay5 days

The days of total hospital stay of the patients will be recorded

Trial Locations

Locations (1)

Hospital Clínico Universidad de Chile

🇨🇱

Santiago, International, Chile

© Copyright 2025. All Rights Reserved by MedPath